Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic value for cardiovascular risk stratification across different patient populations. The incremental value of Cys‐C beyond established cardiac and renal biomarkers remains incompletely explored. Methods and Results S...

Full description

Bibliographic Details
Main Authors: Simon Correa, David A. Morrow, Eugene Braunwald, Richard Y. Davies, Erica L. Goodrich, Sabina A. Murphy, Christopher P. Cannon, Michelle L. O'Donoghue
Format: Article
Language:English
Published: Wiley 2018-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
biomarker
cystatin C
prognosis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.009077

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.009077

Similar Items